Paraneoplastic Neurological Disorders, Volume 200 covers new, recent descriptions of autoantibodies against neuronal cell surface antigens (only partly associated with paraneoplastic disorders) and the introduction of new immuno-oncological drugs that can contribute to diseases that are pathogenetically indistinguishable from paraneoplastic syndromes. Besides investigating the pathogenetic mechanisms of these disorders, this book also explores what the introduction of new drugs used in immune checkpoint inhibitor cancer therapy are teaching us in terms of immunopathogenesis. Following sections…mehr
Paraneoplastic Neurological Disorders, Volume 200 covers new, recent descriptions of autoantibodies against neuronal cell surface antigens (only partly associated with paraneoplastic disorders) and the introduction of new immuno-oncological drugs that can contribute to diseases that are pathogenetically indistinguishable from paraneoplastic syndromes. Besides investigating the pathogenetic mechanisms of these disorders, this book also explores what the introduction of new drugs used in immune checkpoint inhibitor cancer therapy are teaching us in terms of immunopathogenesis. Following sections present individual syndromes (phenotypical clinical manifestations) of the CNS, PNS, NMJ, and muscle. Finally, the book investigates the role of antibody markers that differentiate by cytoplasmic, nuclear, and neuronal cell surface reactivities. Side effects of the new immuno-oncological drugs increasingly used in cancer therapy are also covered.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Section I. Introduction and Overview 1. Introduction and overview of immunopathological mechanisms and future directions 2. Changing landscape in the field of paraneoplastic neurology: Personal Perspectives over a 35-year career 3. Pathogenesis and immunopathology of paraneoplastic disorders Section II. Paraneoplastic neurological syndromes 4. Epidemiology of paraneoplastic neurologic syndromes 5. Clinical approach to diagnosis of paraneoplastic neurological syndromes 6. Overview of treatment strategies in paraneoplastic neurological syndromes 7. Methods to Detect Paraneoplastic Antibodies 8. Paraneoplastic encephalitis 9. Autoimmune and paraneoplastic seizures 10. Paraneoplastic Cerebellar and Brainstem Disorders 11. Paraneoplastic/autoimmune myelopathies 12. Paraneoplastic vision loss 13. Paraneoplastic movement disorders 14. Movement disorders associated with pediatric encephalitis 15. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders 16. Paraneoplastic autonomic neuropathies and GI dysmotility 17. Myasthenia Gravis - Pathophysiology, diagnosis and treatment 18. Lambert-Eaton myasthenic syndrome 19. Paraneoplastic myopathies Section III. Paraneoplastic autoantibodies 20. Intracellular paraneoplastic autoantibodies 21. Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes 22. Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice Section IV. Paraneoplastic neurological and autoantibody accompaniments of cancer 23. Paraneoplastic Autoimmune Neurological Disorders associated with Thymoma 24. Paraneoplastic Neurologic Manifestations of Neuroendocrine tumors 25. Paraneoplastic Neurological Syndrome associated with Gynaecological and Breast malignancies 26. Hematological malignancies and hematopoietic stem cell transplantation 27. Paraneoplastic neurological syndrome and autoantibody accompaniments of germ cell tumors Section V. Neurological complications of cancer immunotherapy 28. Neurological manifestations of autoimmunity with immune checkpoint inhibitors
Section I. Introduction and Overview 1. Introduction and overview of immunopathological mechanisms and future directions 2. Changing landscape in the field of paraneoplastic neurology: Personal Perspectives over a 35-year career 3. Pathogenesis and immunopathology of paraneoplastic disorders Section II. Paraneoplastic neurological syndromes 4. Epidemiology of paraneoplastic neurologic syndromes 5. Clinical approach to diagnosis of paraneoplastic neurological syndromes 6. Overview of treatment strategies in paraneoplastic neurological syndromes 7. Methods to Detect Paraneoplastic Antibodies 8. Paraneoplastic encephalitis 9. Autoimmune and paraneoplastic seizures 10. Paraneoplastic Cerebellar and Brainstem Disorders 11. Paraneoplastic/autoimmune myelopathies 12. Paraneoplastic vision loss 13. Paraneoplastic movement disorders 14. Movement disorders associated with pediatric encephalitis 15. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders 16. Paraneoplastic autonomic neuropathies and GI dysmotility 17. Myasthenia Gravis - Pathophysiology, diagnosis and treatment 18. Lambert-Eaton myasthenic syndrome 19. Paraneoplastic myopathies Section III. Paraneoplastic autoantibodies 20. Intracellular paraneoplastic autoantibodies 21. Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes 22. Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice Section IV. Paraneoplastic neurological and autoantibody accompaniments of cancer 23. Paraneoplastic Autoimmune Neurological Disorders associated with Thymoma 24. Paraneoplastic Neurologic Manifestations of Neuroendocrine tumors 25. Paraneoplastic Neurological Syndrome associated with Gynaecological and Breast malignancies 26. Hematological malignancies and hematopoietic stem cell transplantation 27. Paraneoplastic neurological syndrome and autoantibody accompaniments of germ cell tumors Section V. Neurological complications of cancer immunotherapy 28. Neurological manifestations of autoimmunity with immune checkpoint inhibitors
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826